In this study I compare the analgesic effect of two drugs
Phase 2
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/08/056029
- Lead Sponsor
- Gitanjali
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient undergoing mastectomy and willing to participate in the study
Patient with no history of hypersensitivity to drugs used in this study
Exclusion Criteria
Patient allergic to drugs and contraindication to periphersl nerve blocks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the quality duration of postoperative analgesiaTimepoint: 30 mins
- Secondary Outcome Measures
Name Time Method Sedation score <br/ ><br>Patient satisfactory score likert scale <br/ ><br>Serial blood sugar levels <br/ ><br>PONVTimepoint: 24 hours